BridgeMD
New treatment option for COPD (Chronic Obstructive Pulmonary Disease)
Official title Isoinertial Training in Patients With COPD
ClinicalTrials.gov ID: NCT07605117
What this study is testing
- What it's testing
- Isoinertial training is emerging as a potentially effective strategy to improve strength and functionality in older people diagnosed with chronic obstructive pulmonary disease (COPD), due to its influence on muscle mass and neuromuscular efficiency. COPD is characterized by systemic alterations, including peripheral muscle dysfunction; which contributes to patient functional limitation, and reduces patients' quality of life.
- Time commitment: about 8 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- People between 50 - 80 years of age diagnosed with moderate or severe COPD
- No acute exacerbations in the last 4 weeks
- Sufficient functional capacity to exercise
- Signed informed consent
You likely can't join if
- Presence of neurological, musculoskeletal, or cardiovascular diseases that significantly limit exercise performance or compromise participant safety...
- Contraindications to exercise participation according to medical evaluation.
- Recent surgeries in the past 3 months
- Simultaneous participation in other exercise programs
- Cognitive disorders
The study team makes the final eligibility decision.
Where it's taking place
- Bogotá, Bogotá, DC, Colombia
- Ibague, Ibagué, Colombia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 8 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bogotá, Bogotá, DC, Colombia; Ibague, Ibagué, Colombia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.